Tofacitinib Clinical Trials
12 recruitingDrug
Phase 44Phase 33Early Phase 12Phase 21Not Applicable1
Showing 1–12 of 12 trials
Recruiting
Phase 2
Safety of Tofacitinib, an Oral Janus Kinase Inhibitor, in Primary Sjogren Disease
Sjogren's Syndrome
National Institute of Dental and Craniofacial Research (NIDCR)60 enrolled1 locationNCT07281456
Recruiting
Phase 3
Study of Salvage Therapy to Treat Patients With Granulomatosis With Polyangiitis
Granulomatosis With Polyangiitis
Assistance Publique - Hôpitaux de Paris42 enrolled1 locationNCT04871191
Recruiting
Phase 3
Trial of Sequential Medications AfteR TNFi Failure in Juvenile Idiopathic Arthritis
Polyarticular Course Juvenile Idiopathic Arthritis (JIA)
Duke University400 enrolled5 locationsNCT06654882
Recruiting
Not Applicable
The Efficacy and Safety of Anti-inflammation Treatment (Hirudoid Introduction Followed by Yellow Light Therapy) Combined With Tofacitinib and Doxycycline in Chinese Adult Patients With Mild to Moderate Erythematous Telangiectatic Rosacea
Erythematotelangiectatic Rosacea
The Fourth Affiliated Hospital of Zhejiang University School of Medicine186 enrolled1 locationNCT07343635
Recruiting
Phase 4
A Study of Vedolizumab With Tofacitinib in Adults With Ulcerative Colitis (UC)
Ulcerative Colitis
Takeda65 enrolled49 locationsNCT06095128
Recruiting
Early Phase 1
Comparison Between Oral Methotrexate and Tofacitinib in Chronic Plaque Psoriasis
Psoriasis
Lahore General Hospital75 enrolled1 locationNCT07261306
Recruiting
Phase 3
Treatment of Rheumatoid Arthritis With DMARDs: Predictors of Response
Rheumatoid Arthritis
University of Nebraska400 enrolled1 locationNCT03414502
Recruiting
Phase 4
Effect of Tofacitinib on Coagulation and Platelet Function, and Its Role in Thromboembolic Events
Ulcerative ColitisThromboembolism
Fundación de Investigación Biomédica - Hospital Universitario de La Princesa30 enrolled1 locationNCT05313620
Recruiting
Phase 4
A Randomized, Controlled, Open-label, Multicenter Clinical Trial Comparing the Efficacy and Safety of a Precision Treatment Regimen Based on Clinical-molecular Phenotypes with a Conventional Treatment Regimen in the Treatment of Patients with Active Takayasu's Arteritis
Takayasu Arteritis
Shanghai Zhongshan Hospital124 enrolled1 locationNCT06498089
Recruiting
Phase 4
Comparison of Tofacitinib and Methotrexate in Takayasu's Arteritis
Takayasu Arteritis
Shanghai Zhongshan Hospital76 enrolled1 locationNCT05102448
Recruiting
Efficacy and Safety of JAK Inhibitors in Patients With AA: RWE Study
Alopecia AreataJanus Kinase Inhibitors
Second Affiliated Hospital, School of Medicine, Zhejiang University150 enrolled1 locationNCT06573593
Recruiting
Early Phase 1
Evaluation of the Efficacy and Safety of Methylprednisolone Combined With the JAK Inhibitors in the Treatment of Toxic Epidermal Necrolysis
Toxic Epidermal Necrolysis
Peng Zhang30 enrolled1 locationNCT06119490